Skip to main content

Purnanand D. Sarma

Equibles does not estimate personal net worth.

About Purnanand D. Sarma

Purnanand D. Sarma was last confirmed as CEO at Immunome Inc. (IMNM) in a filing dated April 20, 2023. Earlier roles on record: Board Member at Immunome Inc. (IMNM) until October 2, 2023. Immunome Inc. reported in an 8-K filed October 4, 2023 that Purnanand D. Sarma resigned as Immunome's board of directors and any respective committee membership of Immunome's board of directors, effective October 2, 2023. The same filing states: “The resignation of each of the above referenced directors was not the result of a disagreement with Immunome on any matter relating to its operations, policies or practices.” Immunome Inc. reported in an 8-K filed October 4, 2023 that Purnanand D. Sarma resigned as officer and employee of Immunome, effective October 2, 2023. The same filing states: “The resignation of each of the above referenced directors was not the result of a disagreement with Immunome on any matter relating to its operations, policies or practices.” The proxy statement of Immunome Inc. reports total compensation of $1,437,295 for Purnanand D. Sarma in fiscal 2023, including a base salary of $440,820. Disclosed compensation is on record for 5 fiscal years.

“(ii) Purnanand D. Sarma, Ph.D. resigned from Immunome's board of directors and any respective committee membership of Immunome's board of directors, and resigned as an officer and employee of Immunome for Good Reason under the terms of his Amended and Restated Employment Agreement with Immunome, dated October 14, 2020, in each case, effective as of the closing of the Merger”
“The resignation of each of the above referenced directors was not the result of a disagreement with Immunome on any matter relating to its operations, policies or practices.”
Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing
“(ii) Purnanand D. Sarma, Ph.D. resigned from Immunome's board of directors and any respective committee membership of Immunome's board of directors, and resigned as an officer and employee of Immunome for Good Reason under the terms of his Amended and Restated Employment Agreement with Immunome, dated October 14, 2020, in each case, effective as of the closing of the Merger”
“The resignation of each of the above referenced directors was not the result of a disagreement with Immunome on any matter relating to its operations, policies or practices.”
Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing

Affiliation history

Company network

Biotechnology · Healthcare

CEO, Board Member

2019-01-01–2023-10-02

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Immunome Inc. (IMNM) $440,820 $1,437,295
2022 Immunome Inc. (IMNM) $540,000 $990,309
2021 Immunome Inc. (IMNM) $540,000 $2,111,914
2020 Immunome Inc. (IMNM) $435,000 $1,695,002
2019 Immunome Inc. (IMNM) $233,333 $339,910

Recent activity